Pre-Clinical Studies

Our pre-clinical studies unit serves the pre-clinical assay development needs of both the pharmaceutical and biotech industries. Our dedicated project teams develop and validate novel assays for specific clients. This involves sourcing of known reagents and custom development, using novel reagents. In addition, we oversee protocol development, assess technological resources and, when necessary, support the regulatory approval process.

We are backed by the expertise and diligent work of the medical professionals at Genzyme Genetics. Thanks in part to this superior team of medical professionals, we are able to utilize a number of state-of-the-art technologies for our studies including immunohistochemistry (IHC), cytogenetics, fluorescence in situ hybridization (FISH), molecular genetics, custom tissue microarrays and flow cytometry.

Although we offer a number of products to our clients, our most important product is our commitment to quality. We work tirelessly to ensure that our studies are fully validated and of the highest quality.

Our dedicated project teams use the appropriate technologies to provide each pre-clinical study with a customized approach. Coupling a breadth of experience with a personal approach to each study, we provide each client with first-class results. All work for each study is done in compliance with GLP/GCP, CLIA and CAP regulations.

For more information on our pre-clinical studies, please e-mail Victoria Reese at victoria.reese@genzyme.com, Gina Wallar at gina.wallar@genzyme.com or Cathy Arnold at cathy.arnold@genzyme.com.